Managing Insomnia Associated with Bupropion Therapy

Dose Timing and Formulation

Administer the first bupropion dose in the morning upon waking and ensure the second dose (if using SR) is taken no later than 3 PM to reduce nighttime sleep disruption. 1
Switching from twice‑daily Bupropion SR to a single morning dose of Bupropion XL 300 mg can improve sleep quality by providing steady daytime drug levels without an afternoon dose that interferes with sleep. 1
Do not exceed 300 mg/day for depressive indications (or 450 mg/day maximum for any indication) because higher doses increase adverse effects without additional therapeutic benefit. 1

If insomnia persists after 2–3 weeks of optimized bupropion timing, add low‑dose trazodone (50–100 mg) at bedtime; this combination has been reported as safe. [2][1]
Trazodone’s sedating properties and minimal anticholinergic activity make it suitable for patients receiving activating antidepressants such as bupropion. 2
Short‑acting benzodiazepine‑receptor agonists (e.g., zolpidem 5–10 mg or zaleplon 10 mg) may be used on a short‑term basis for residual insomnia. 2
Long‑acting benzodiazepines (e.g., flurazepam) should be avoided because they can cause residual daytime sedation. 2
Ramelteon 8 mg at bedtime is an alternative non‑scheduled melatonin‑receptor agonist for sleep‑onset insomnia. 2

Monitor patients for 6–8 weeks at therapeutic bupropion doses before concluding that insomnia is not medication‑related; full antidepressant effects typically require this time frame. 1

If insomnia remains severe and functionally impairing after 4 weeks despite timing optimization and adjunctive sleep aids, consider switching to an alternative antidepressant. [1][3]
Mirtazapine 7.5–30 mg taken at bedtime provides antidepressant efficacy with sedating properties that improve sleep. 3
Selective serotonin reuptake inhibitors (e.g., escitalopram 10–20 mg, sertraline 50–200 mg) are associated with lower insomnia rates than bupropion, though they may increase sexual dysfunction. 1
Taper bupropion over 10–14 days before initiating a new antidepressant to minimize withdrawal symptoms. 3

The most common cause of bupropion‑induced insomnia is taking the second SR dose after 3 PM; avoid this timing. 1
Do not add SSRIs solely to manage insomnia, as they do not reliably improve sleep and increase polypharmacy. 3
Do not discontinue bupropion abruptly; a 10–14‑day taper is required to prevent mood destabilization and withdrawal. 3
Do not exceed a total daily dose of 450 mg, as higher doses raise seizure risk without added efficacy. 1
Avoid concurrent use of alcohol or other central nervous system depressants when managing insomnia, due to heightened adverse‑effect risk. 2

Older adults (≥ 65 years): Start with 37.5 mg each morning, titrate by 37.5 mg every 3 days as tolerated, with a maximum of 150 mg twice daily (300 mg total); ensure the second dose is taken before 3 PM. 1
Renal impairment (eGFR < 90 mL/min): Reduce the total daily dose by 50 % (e.g., 150 mg once daily) to prevent drug accumulation that may worsen insomnia. 1